Rheumatoid Arthritis Response to Methotrexate

NCT03535519 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-08-07

No results posted yet for this study

Summary

Observational and prospective study of the ultrasound response to methotrexate in rheumatoid arthritis patients who started methotrexate

Conditions

Interventions

DRUG

Methotrexate

standard of care treatment with methotrexate

Sponsors & Collaborators

  • Nordic Pharma SAS

    collaborator INDUSTRY
  • Juan Carlos Nieto

    lead OTHER

Principal Investigators

  • Juan Carlos Nieto González, PhD · Hospital General Universitario Gregorio Maranon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-07
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535519 on ClinicalTrials.gov